Madrigal Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Madrigal Pharmaceuticals

MDGL 474.98

+6.7%

Nov 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Lynn who wrote (7)	6/1/2018 10:02:46 AM
From: Lynn	of 138

Benzinga Pro's 5 Stocks To Watch Today Jayson Derrick , Benzinga Staff Writer June 01, 2018 9:07am [snip] Viking Therapeutics Inc VKTX 1.35% was trading higher by more than 8 percent early Friday morning on top of Thursday's 50 percent gain. The pharmaceutical company's stock moved in sympathy with its peer Madrigal Pharmaceuticals Inc MDGL 3%, which announced encouraging Phase 2 data for its NASH candidate. Investors and traders are likely assuming the successful Phase 2 study for Madrigal bodes well for Viking's similar VK2809 NASH candidate. [snip to end] benzinga.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next